ReviewBritish journal of clinical pharmacology2020

Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift?

Geoffrey Alan Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.